| IPAQ |
Lipohypertrophy
|
Lipoatrophy
|
| Prevalence Ratio
(95% CI) |
P
value |
Prevalence Ratio
(95% CI) |
P
value |
Men
Actives*
Insufficient physical activity |
1.0
1.31 (1.07-1.60) |
0.008 |
1.0
0.93 (0.80-1.08) |
0.3 |
| Model 1* |
1.31 (1.07-1.59) |
0.008 |
0.93 (0.80-1.07) |
0.3 |
| Model 2** |
1.30 (1.07-1.59) |
0.009 |
0.94 (0.91-1.08) |
0.4 |
| Model 3*** |
1.30 (1.07-1.58) |
0.01 |
0.94 (0.82-1.09) |
0.4 |
| Model 4**** |
1.30 (1.07-1.58) |
0.009 |
0.94 (0.82-1.09) |
0.4 |
| Model 5***** |
1.34 (1.10-1.63) |
0.004 |
0.93 (0.80-1.07) |
0.3 |
| Model 6****** |
1.34 (1.10-1.63) |
0.004 |
0.92 (0.80-1.07) |
0.3 |
Women
Actives*
Insufficient physical activity |
1.0
0.91 (0.78-1.06) |
0.2 |
1.0
0.87 (0.74-1.03) |
0.10 |
| Model 1* |
0.91 (0.78-1.06) |
0.2 |
0.88 (0.75-1.03) |
0.11 |
| Model 2** |
0.92 (0.79-1.08) |
0.3 |
0.89 (0.76-1.04) |
0.15 |
| Model 3*** |
0.93 (0.79-1.08) |
0.3 |
0.89 (0.76-1.05) |
0.17 |
| Model 4**** |
0.92 (0.79-1.08) |
0.3 |
0.90 (0.76-1.06) |
0.19 |
| Model 5***** |
0.93 (0.80-1.08) |
0.3 |
0.90 (0.77-1.06) |
0.2 |
| Model 6****** |
0.93 (0.80-1.08) |
0.3 |
0.91 (0.77-1.07) |
0.2 |
*adjusted for age
**adjusted for age and race
***adjusted for age, race and education
****adjusted for age, race, education and pack years
*****adjusted for age, race, education, binge drinking and CD4
******adjusted for age, race, education, binge drinking, CD4 and HAART
|
